You are here

Hum Mutat DOI:10.1002/humu.24051

AutoPVS1: An automatic classification tool for PVS1 interpretation of null variants.

Publication TypeJournal Article
Year of Publication2020
AuthorsXiang, J, Peng, J, Baxter, S, Peng, Z
JournalHum Mutat
Date Published2020 May 22
ISSN1098-1004
Abstract

Null variants are prevalent within human genome, and their accurate interpretation is critical for clinical management. In 2018, the ClinGen Sequence Variant Interpretation (SVI) Working Group refined the only criterion with a very strong pathogenicity rating (PVS1). To streamline PVS1 interpretation, we have developed an automatic classification tool with a graphical user interface called AutoPVS1. The performance of AutoPVS1 was assessed using 56 variants manually curated by ClinGen's SVI Working Group; it achieved an interpretation concordance of 93% (52/56). A further analysis of 28,586 putative loss-of-function variants by AutoPVS1 demonstrated that at least 27.7% of them do not reach a very strong strength level, 17.5% because of variant-specific issues and 10.2% due to disease mechanism considerations. Notably, 41.0% (1,936/4,717) of splicing variants were assigned a decreased preliminary PVS1 strength level, a significantly greater fraction than in frameshift variants (13.2%) and nonsense variants (10.8%). Our results reinforce the necessity of considering variant-specific issues and disease mechanisms in variant interpretation and demonstrate that AutoPVS1 meets an urgent need by enabling biocurators to easily assign accurate, reliable and reproducible PVS1 strength levels in the process of variant interpretation. AutoPVS1 is publicly available at http://autopvs1.genetics.bgi.com/. This article is protected by copyright. All rights reserved.

DOI10.1002/humu.24051
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/32442321?dopt=Abstract

Alternate JournalHum. Mutat.
PubMed ID32442321